Global Adipose-derived Stem Cell Market

Report ID : 1360 | Published : 2022-09-14 | Pages: | Format: PDF/EXCEL

The Global Adipose-derived Stem Cell Market is estimated to be worth US$ 1035.13 million in 2021 and is anticipated to grow at a CAGR of 13.05% from 2022 to 2030, according to the most recent InsightAce Analytic research. ADSCs are called multipotent cells, and they play several intercellular roles in the renewal and regeneration of other tissues and cell types in the body. This is because these cells produce and secrete various cytokines, chemokines, and growth factors that function in a paracrine manner in in-vivo tissue regeneration. It is usual to extract them using liposuction or direct excision technique from abdominal adipose (fat) tissues. For instance, Adipose-derived stem cells (ADSCs) have the potential to differentiate into musculoskeletal system cell types like tendons, ligaments, and articular cartilage. The Isolation is a success rate of 100%, and the yield from adipose tissue is 40, significantly more significant than that from bone marrow. In addition, the number of cells does not seem to decrease with age, making this type of cell appealing for extracting MSCs and progenitor cells.


Although adipose-derived stem cell therapy is often regarded as a safe operation with few potential adverse effects, difficulties can arise with any kind of medical treatment. Rising regulatory support for clinical trials of ADSCs pharmaceuticals and rising investment in the research and development of regenerative therapies are two significant factors propelling the growth of the adipose-derived stem cell market. To hasten the search for and Isolation of novel therapeutics, also there has been a rise in strategic partnerships formed between academic research institutions and pharmaceutical companies. For instance, In 2019, InGeneron Increases Its Series D Financing Amount to 43 Million Dollars in Order to Bring Regenerative Cell Therapy to Clinics.


Infection is a potential complication of adipose-derived stem cell therapy due to the possibility that disease-causing bacteria, viruses, or other pathogens will be introduced during the processing phase. Also, there are some limitations to preserving and delivering the cells, which will restrict the market growth.
The global Adipose-derived Stem Cell Market is segmented in five main segments. First is Cell type which includes Autologous and Allogeneic stem cells. Second segment is product type which comprises cell line, culture media, media, sera and reagents. The third segment is disease conditions. This segment has cancer, obesity, wounds and injuries, cardiovascular diseases, Musculoskeletal diseases and others. The fourth segment has Therapeutic and research as sub-segments which will be going to lead among all the segmentation for the forecasting period. The last segment is based on end-user industries, which are cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Other end-user industries.


Regionally North America will represent an entire market of ADSCs. Research and development funding has been increasing continuously over the last decade, which will result in early and more advancements in this therapeutic area.

Some key market players are Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc., Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast Ltd., Cytori Therapeutics, Antria, Inc., ThermoFisher Scientific, American CrysoStem, Merck KGaA, and Other Prominent Players.


• Allocure, Inc.
• Celgene Corporation
• Pluristem Therapeutics, Inc.
• Intrexon, Inc.
• Celleris SA
• Tissue Genesis, Inc.
• Mesoblast Ltd.
• Cytori Therapeutics
• Antria, Inc.
• ThermoFisher Scientific,
• American CrysoStem
• Merck KGaA
• Others

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Adipose-derived Stem Cell Market Snapshot

Chapter 4. Global Adipose-derived Stem Cell Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Cell Type Estimates & Trend Analysis

5.1. By Cell Type & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Cell Type:

5.2.1. Autologous stem cells

5.2.2. Allogeneic stem cells

Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis

6.1. By Product Type & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Product Type:

6.2.1. Cell line

6.2.2. Culture Media

6.2.3. Media

6.2.4. Sera

6.2.5. Reagents

Chapter 7. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis

7.1. By Disease Indication & Market Share, 2020 & 2030

7.2. Market Size (Value US Disease Indication of Operation:

7.2.1. Cancer

7.2.2. Obesity

7.2.3. Wounds and Injuries

7.2.4. Cardiovascular diseases

7.2.5. Musculoskeletal diseases

7.2.6. Others

Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis

8.1. By Application & Market Share, 2020 & 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:

8.2.1. Therapeutic

8.2.2. Research

8.2.3. Others

Chapter 9. Market Segmentation 5: By End-user Estimates & Trend Analysis

9.1. By End-user & Market Share, 2020 & 2030

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-user:

9.2.1. Cell banks & Tissue banks

9.2.2. Research laboratories and Academic institutes

9.2.3. Hospitals and Trauma centers

9.2.4. Others

Chapter 10. Adipose-derived Stem Cell Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Cell Type, 2022-2030

10.1.2. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2030

10.1.3. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2022-2030

10.1.4. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2022-2030

10.1.5. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2022-2030

10.1.6. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by country, 2022-2030

10.2. Europe

10.2.1. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2022-2030

10.2.2. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2022-2030

10.2.3. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2022-2030

10.2.4. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2022-2030

10.2.5. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2022-2030

10.2.6. Europe Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2022-2030

10.3. Asia Pacific

10.3.1. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2022-2030

10.3.2. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2022-2030

10.3.3. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2022-2030

10.3.4. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2022-2030

10.3.5. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2022-2030

10.3.6. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2022-2030

10.4. Latin America

10.4.1. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million)

10.4.2. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million)

10.4.3. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2022-2030

10.4.4. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2022-2030

10.4.5. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2022-2030

10.4.6. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2022-2030

10.5. Middle East & Africa

10.5.1. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million)

10.5.2. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million)

10.5.3. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2022-2030

10.5.4. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2022-2030

10.5.5. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2022-2030

10.5.6. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2022-2030

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles 

11.2.1. Allocure, Inc.

11.2.2. Celgene Corporation

11.2.3. Pluristem Therapeutics, Inc.

11.2.4. Intrexon, Inc.

11.2.5. Celleris SA

11.2.6. Tissue Genesis, Inc.

11.2.7. Mesoblast Ltd.

11.2.8. Cytori Therapeutics

11.2.9. Antria, Inc.

11.2.10. ThermoFisher Scientific,

11.2.11. American CrysoStem

11.2.12. Merck KGaA

11.2.13. Others

11.2.14. Other Prominent Players

Global Adipose-derived Stem Cell Market, by Cell Type, 2022-2030 (Value US$ Mn)
• Autologous stem cells
• Allogeneic stem cells
Global Adipose-derived Stem Cell Market, by Product Type, 2022-2030 (Value US$ Mn)
• Cell line
• Culture Media
• Media
• Sera
• Reagents

Global Adipose-derived Stem Cell Market, by Disease Indication, 2022-2030 (Value US$ Mn)
• Cancer
• Obesity
• Wounds and Injuries
• Cardiovascular diseases
• Musculoskeletal diseases
• Others


Global Adipose-derived Stem Cell Market, by Application, 2022-2030 (Value US$ Mn)
• Therapeutic
• Research
• Others
Global Adipose-derived Stem Cell Market, by End-User Industry, 2022-2030 (Value US$ Mn)
• Cell banks & Tissue banks
• Research laboratories and Academic institutes
• Hospitals and Trauma centers
• Others

Global Adipose-derived Stem Cell Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada

Europe Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients